FP7
PHARMATRAIN
Pharmaceutical Medicine Training Programme
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 7,631,528
- EU contribution
- EUR 3,510,300
- Participants
- 46 from 15 countries
- Topic
- FP7_IMI-JU-01-2008-16
- Grant agreement
- 115013
Coordinated by PharmaTrain Federation (CHSwitzerland).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| PharmaTrain Federation | CHSwitzerland | Coordinator | EUR 290,000 | PIC (1.00) |
| Universitat Wien | ATAustria | Participant | EUR 38,333 | known name (0.95) |
| Vienna School of Clinical Research | ATAustria | Participant | EUR 56,933 | PIC (1.00) |
| Amgen | BEBelgium | Participant | Not stated | PIC (1.00) |
| European Forum for Good Clinical Practice | BEBelgium | Participant | EUR 133,233 | PIC (1.00) |
| European Organisation for Research and Treatment of Cancer Aisbl | BEBelgium | Participant | EUR 23,333 | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| PHARMED asbi | BEBelgium | Participant | EUR 213,834 | PIC (1.00) |
| DIA Europe GmbH | CHSwitzerland | Participant | EUR 18,333 | PIC (1.00) |
| Fondation Health Sciences e-Training | CHSwitzerland | Participant | EUR 68,333 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Swissmedic | CHSwitzerland | Participant | EUR 13,333 | known name (0.95) |
| Universitat Basel | CHSwitzerland | Participant | EUR 1,063,285 | known name (0.95) |
| Bayer Pharma AG | DEGermany | Participant | Not stated | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| PME Institute for Education in Pharmaceutical Medicine | DEGermany | Participant | EUR 15,333 | PIC (1.00) |
| Universitaetsklinikum Essen | DEGermany | Participant | EUR 13,333 | PIC (1.00) |
| Universitaetsklinikum Freiburg | DEGermany | Participant | EUR 13,333 | PIC (1.00) |
| Kobenhavns Universitet | DKDenmark | Participant | EUR 18,333 | known name (0.95) |
| Novo Nordisk A/S | DKDenmark | Participant | Not stated | PIC (1.00) |
| Almirall SA | ESSpain | Participant | Not stated | PIC (1.00) |
| Esteve Pharmaceuticals, SA | ESSpain | Participant | Not stated | PIC (1.00) |
| Universidad Pompeu Fabra | ESSpain | Participant | EUR 18,333 | PIC (1.00) |
| Universitat Autonoma de Barcelona | ESSpain | Participant | EUR 18,333 | known name (0.97) |
| Universitat de Barcelona | ESSpain | Participant | EUR 38,333 | known name (0.97) |
| Orion OYJ | FIFinland | Participant | Not stated | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | Not stated | PIC (1.00) |
| Universite Louis Pasteur | FRFrance | Participant | EUR 13,333 | PIC (1.00) |
| Universite Lyon 1 Claude Bernard | FRFrance | Participant | EUR 205,000 | PIC (1.00) |
| Cardiff University | GBUnited Kingdom | Participant | EUR 50,000 | known name (0.95) |
| Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom | GBUnited Kingdom | Participant | EUR 195,000 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 42,220 | known name (0.95) |
| Medicines and Healthcare products Regulatory Agency | GBUnited Kingdom | Participant | EUR 18,333 | known name (0.95) |
| University of Surrey | GBUnited Kingdom | Participant | EUR 10,888 | known name (0.95) |
| Semmelweis Egyetem | HUHungary | Participant | EUR 314,800 | known name (0.95) |
| Hibernia College | IEIreland | Participant | EUR 124,333 | PIC (1.00) |
| The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin | IEIreland | Participant | EUR 35,000 | PIC (1.00) |
| Universita Cattolica del Sacro Cuore | ITItaly | Participant | EUR 13,333 | known name (0.95) |
| International Federation of Associations of Pharmaceutical Physicians | NLNetherlands | Participant | EUR 360,000 | PIC (1.00) |
| Stichting Lygature | NLNetherlands | Participant | Not stated | PIC (1.00) |
| Faculty of Medicine, University of Belgrade | RSSerbia | Participant | EUR 23,000 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| European Federation for Pharmaceutical Sciences | SESweden | Participant | EUR 41,666 | PIC (1.00) |
| Goeteborgs Universitet | SESweden | Participant | Not stated | PIC (1.00) |
| Karolinska University Hospital | SESweden | Participant | EUR 2,780 | known name (0.95) |
Changes of the consortium
First seen on with 46 participants from 15 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.